FLT3 (NM_004119) Human Mutant ORF Clone

Specifications

Product Data
Product Name	FLT3 (NM_004119) Human Mutant ORF Clone
Mutation Description	D324N
Affected Codon#	324
Affected NT#	970
Nucleotide Mutation	FLT3 Mutant (D324N), Myc-DDK-tagged ORF clone of Homo sapiens fms-related tyrosine kinase 3 (FLT3) as transfection-ready DNA
Effect	Myeloid leukaemia, increased risk, association with
Synonyms	CD135; FLK-2; FLK2; STK1
Vector	pCMV6-Entry
Tag	Myc-DDK
ACCN	NM_004119
ORF Size	2979 bp
Restriction Sites	SgfI-MluI      Cloning Scheme for this gene
OTI Disclaimer	The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info
OTI Annotation	This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene.
Reference Data
RefSeq	NP_004110
RefSeq Size	2979 bp
RefSeq ORF	2982 bp
Locus ID	2322
Protein Families	Druggable Genome, ES Cell Differentiation/IPS, Protein Kinase, Transmembrane
Protein Pathways	Acute myeloid leukemia, Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Pathways in cancer
MW	109.2 kDa
Gene Summary	This gene encodes a class III receptor tyrosine kinase that regulates hematopoiesis. This receptor is activated by binding of the fms-related tyrosine kinase 3 ligand to the extracellular domain, which induces homodimer formation in the plasma membrane leading to autophosphorylation of the receptor. The activated receptor kinase subsequently phosphorylates and activates multiple cytoplasmic effector molecules in pathways involved in apoptosis, proliferation, and differentiation of hematopoietic cells in bone marrow. Mutations that result in the constitutive activation of this receptor result in acute myeloid leukemia and acute lymphoblastic leukemia. [provided by RefSeq, Jan 2015]

*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.